NewAmsterdam Pharma (NAMS) Total Current Liabilities (2021 - 2026)
NewAmsterdam Pharma (NAMS) recorded Total Current Liabilities of $72.97 million in Q2 2026, up 99.9% from $36.51 million a year earlier and up 8.2% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Total Current Liabilities (2021 - 2026) Analysis & Trends
At the end of FY2025, NewAmsterdam Pharma reported Total Current Liabilities of $85.79 million, down 19.8% from FY2024.
- Annual Total Current Liabilities has a four-year compound annual growth rate of 64.6% (FY2021 to FY2025).
- Across earlier years, Total Current Liabilities came in at $106.92 million in FY2024 (+114.3%), $49.9 million in FY2023 (+38.4%), $36.06 million in FY2022 (+208.4%) and $11.69 million in FY2021.
- Quarterly Total Current Liabilities has ranged from $11.3 million in Q4 2021 to $106.92 million in Q4 2024 over the past five years.
- On a year-over-year basis, Total Current Liabilities rose in four of the last seven quarters, with growth averaging 35.6%.
- Peak year-over-year performance for Total Current Liabilities in the last five years was growth of 220.1% in Q4 2022, against a decline of 31.5% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $67.42 million (Q1 2026), $85.79 million (Q4 2025) and $58.27 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 47.74 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 54.90 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 41.64 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 27.73 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 31.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 31.55 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 25.50 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.02 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 32.65 Bn |
| 10 | NewAmsterdam Pharma | 2.66 Bn | 49.48 Mn | - | 72.97 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 72.97 Mn |
| Mar 31, 2026 | 67.42 Mn |
| Dec 31, 2025 | 85.79 Mn |
| Sep 30, 2025 | 58.27 Mn |
| Jun 30, 2025 | 36.51 Mn |
| Mar 31, 2025 | 40.91 Mn |
| Dec 31, 2024 | 106.92 Mn |
| Sep 30, 2024 | 41.26 Mn |
| Jun 30, 2024 | 45.31 Mn |
| Mar 31, 2024 | 59.73 Mn |
| Dec 31, 2023 | 49.90 Mn |
| Jun 30, 2023 | 41.66 Mn |
| Dec 31, 2022 | 37.80 Mn |
| Dec 31, 2021 | 11.19 Mn |
API Access
NewAmsterdam Pharma Total Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-current-liabilities", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();